Heart’s Mechanical Forces Block Tumor Growth in Mice | Science News
- The heart’s natural mechanical action—its rhythmic beating—appears to inhibit the growth of cancer cells within the heart muscle itself, according to a study published in Science on April...
- The study, which involved both mouse models and human tissue samples, revealed that mechanical load reduces cancer cell proliferation in the myocardium.
- Researchers investigated the role of mechanical load using in vivo cancer models and ex vivo engineered heart tissues.
The heart’s natural mechanical action—its rhythmic beating—appears to inhibit the growth of cancer cells within the heart muscle itself, according to a study published in Science on April 23, 2026. Researchers found that the physical forces generated by heart contractions and blood pressure changes disrupt cancer cell proliferation, offering a potential explanation for why heart cancer is relatively rare.
The study, which involved both mouse models and human tissue samples, revealed that mechanical load reduces cancer cell proliferation in the myocardium. This protective effect is linked to changes in how cancer cells regulate their genetic material, specifically decreasing histone methylation and chromatin compaction.
Mechanical Forces and Cancer Cell Behavior
Researchers investigated the role of mechanical load using in vivo cancer models and ex vivo engineered heart tissues. Their findings indicate that the constant stretching and compressing of the heart muscle creates an environment hostile to cancer cell growth. This mechanical stress appears to alter the accessibility of genes related to cell proliferation, effectively putting the brakes on tumor development.

Our results uncover how mechanical forces protect the heart from cancer and suggest potential strategies for cancer therapy based on mechanical stimulation.
Science, April 23, 2026
Spatial transcriptomics of human cardiac metastases further supported these findings, showing decreased histone methylation and chromatin compaction in cancer cells exposed to mechanical forces. This suggests the mechanism is relevant in human patients, not just in laboratory models.
Nesprin-2: A Key Mechanosensor
The study identified Nesprin-2 as a crucial molecule in sensing these mechanical forces. Nesprin-2 plays a role in connecting the cell’s internal structure to the extracellular matrix, allowing cells to respond to physical cues from their environment. By sensing the mechanical load, Nesprin-2 triggers changes within the cancer cells that suppress their ability to proliferate.
The researchers noted that cardiomyocytes, the muscle cells of the heart, stop proliferating after birth. This observation led them to hypothesize that the mechanisms preventing cardiac regeneration might also offer protection against cancer. The current study provides evidence supporting this connection, demonstrating how mechanical forces contribute to both limited regeneration and cancer resistance in the heart.
Implications for Cancer Therapy
The findings open up potential avenues for developing new cancer therapies. The study suggests that mechanical stimulation could be used as a strategy to inhibit tumor growth in other parts of the body, not just the heart. However, researchers caution that further investigation is needed to fully understand the complex interplay between mechanical forces and cancer cell behavior.

While the heart rarely develops cancer, secondary cancers—metastases—can occur in the heart. Understanding how the heart’s unique mechanical environment protects against cancer could lead to strategies for preventing or treating these secondary tumors. The research team plans to continue exploring the role of Nesprin-2 and other mechanosensors in cancer development, with the goal of translating these findings into clinical applications.
The study was published in the April 23, 2026 issue of Science.
